Everyday Health on MSN

Blockbuster Cancer Drug Keytruda Now Available as a Time-Saving Shot

So-called checkpoint proteins on immune cells serve as gatekeepers that are supposed to keep foreign invaders from entering healthy cells. Certain cancers use these checkpoints to avoid detection.
SurvivorNet on MSN

FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients

The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option for patients. The subcutaneous form of Keytruda showed to deliver the same ...
Yahoo

Blocking PD-1 and VEGF: The bispecific cancer drugs that could best Keytruda

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Merck & Co.’s cancer immunotherapy Keytruda is one of ...
Healthline

When Will I Stop Receiving Keytruda Treatment?

Most people take Keytruda for about 2 years, but this can change depending on how well it works and the side effects experienced. After stopping, it usually takes about 4 months for Keytruda to leave ...
Benzinga.com

Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery

The U.S. Food and Drug Administration (FDA) on Friday approved Merck & Co Inc.’s (NYSE:MRK) Keytruda (pembrolizumab) for adult patients with resectable locally advanced head and neck squamous cell ...
STAT

Detailed data show Summit therapy beat Merck blockbuster Keytruda in late-stage lung cancer trial

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Adam Feuerstein is a senior writer and biotech columnist, reporting on the ...